Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression

被引:9
|
作者
Andresen, Emily L. [1 ,2 ]
Wilson, Kimberly A. [1 ]
Castillo, Adelaida [1 ]
Koopman, Cheryl [1 ]
机构
[1] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA
[2] Palo Alto Univ, Pacific Grad Sch Psychol, Palo Alto, CA USA
关键词
depression; measure; motivation; randomized clinical trial; recruitment; RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC-DISORDERS; ECONOMIC BURDEN; PATIENTS POINT; ATTITUDES; ANTIDEPRESSANTS; SCHIZOPHRENIA; PSYCHOTHERAPY; WILLINGNESS; PREFERENCES;
D O I
10.1097/YIC.0b013e328332055c
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The motivation for clinical trials inventory-depression (MCTI-D) was developed and evaluated for assessing motivations to participate in clinical trials on depression. Sixty-four participants completed the MCTI-D: 40 individuals expressing interest in participating in a randomized clinical trial (RCT); and 24 clinic patients receiving traditional care for depression. Content validity was supported by feedback derived from a panel of experts in depression research and respondents completing the measure. The motivation most frequently endorsed for participating in an RCT was the desire to help others and/or to further science. The potential stigma associated with seeing a psychiatrist was reported to have the least influence. Patients expressed a greater likelihood to participate in RCTs that involved psychotherapy than in experimental medication or placebo-controlled trials. Data from the MCTI-D may provide useful information for depression researchers to consider as possible influences on patients' decisions about whether or not they will participate. Int Clin Psychopharmacol 25:7-16 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [21] Characteristics of Depression Clinical Trials Registered on ClinicalTrials.gov
    Liang, Juan
    He, Peijie
    Wu, Hanting
    Xu, Xiujuan
    Ji, Conghua
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 8787 - 8796
  • [22] Hypnosis for depression: Systematic review of randomized clinical trials with meta-analysis
    Souza, Filipe Luis
    Moura, Murilo Schiefler
    Silva, Juliana Vieira Almeida
    Elkins, Gary
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2024, 57
  • [23] Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression
    Wan, Hong I.
    Soares, Holly
    Waring, Jeffrey F.
    BIOMARKERS IN MEDICINE, 2012, 6 (01) : 119 - 129
  • [24] Intention, Needs, and Expectations of Cancer Patients Participating in Clinical Trials
    Wang, Lan-Hsiang
    Tsai, Yun-Fang
    Chen, Jen-Shi
    Tsay, Pei-Kwei
    CANCER NURSING, 2011, 34 (02) : 117 - 123
  • [25] Mortality during US FDA clinical trials in patients with diabetes, hypertension, depression and schizophrenia
    Khan, Arif
    Mar, Kaysee Fahl
    Gokul, Sagarika
    Brown, Walter A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (01) : 64 - 71
  • [26] Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials
    Ferrer, Rebecca A.
    Morrow, Kathleen M.
    Fisher, William A.
    Fisher, Jeffrey D.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2010, 22 (08): : 997 - 1005
  • [27] Predictors of improved mood over time in clinical trials for major depression
    Marie-Mitchell, A
    Leuchter, AF
    Chou, CP
    Gauderman, WJ
    Azen, SP
    PSYCHIATRY RESEARCH, 2004, 127 (1-2) : 73 - 84
  • [28] Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials
    Majeed, Amna
    Xiong, Jiaqi
    Teopiz, Kayla M.
    Ng, Jason
    Ho, Roger
    Rosenblat, Joshua D.
    Phan, Lee
    Cao, Bing
    McIntyre, Roger S.
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (01) : 63 - 74
  • [29] A systematic review of Chinese randomized clinical trials of SSRI treatment of depression
    Ying Zhang
    Thomas Becker
    Yongchun Ma
    Markus Koesters
    BMC Psychiatry, 14
  • [30] Diversity Inclusion in Clinical Trials Investigating Esketamine for Depression: A Systematic Review
    Monahan, Katie
    Weyandt, Lisa
    Shepard, Emily
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2023, 31 (03) : 584 - 592